IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Acuta Capital Partners, LLC

Q3 2025 Holdings

Filed 2025-11-14 | 28 holdings | $96.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ocular Therapeutix Inc(OCUL)COM67576A100$13.6M1,165,20614.1%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$13.6M141,52914.0%
Tourmaline BIO Inc(TRML)COM89157D105$12.8M268,45113.3%
Whitehawk Therapeutics Inc(WHWK)COM00032Q104$6.5M3,410,4026.7%
Insmed Inc(INSM)COM PAR $.01457669307$5.6M38,5925.7%
Bright Minds Biosciences Inc(DRUG)COM NEW10919W405$5.1M84,8755.3%
Argen SE(ARGX)SPONSORED ADR04016X101$4.7M6,3794.9%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$4.5M333,2584.7%
Terns Pharmaceuticals Inc(TERN)COM880881107$3.8M502,7973.9%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$3.3M25,1143.4%
Compass Therapeutics Inc(CMPX)COM20454B104$2.9M840,0903.0%
Praxis Precision Medicines I(PRAX)COM74006W207$2.6M49,7512.7%
Surrozen Inc(SRZN)COM NEW86889P208$2.3M178,4152.4%
Ascendis PHA(ASND)SPONSORED ADR04351P101$1.9M9,7922.0%
Krystal Biotech Inc(KRYS)COM501147102$1.9M10,5731.9%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$1.8M101,7771.8%
Taysha Gene Therapies Inc(TSHA)COM SHS877619106$1.5M454,8271.5%
Cogent Biosciences Inc(COGT)COM19240Q201$1.5M102,9071.5%
Zymeworks Inc(ZYME)COM98985Y108$1.4M80,1431.4%
Verastem Inc(VSTM)COM NEW92337C203$1.3M143,4461.3%
Dianthus Therapeutics Inc(DNTH)COM252828108$983.8K25,0001.0%
United Therapeutics Corp(UTHR)COM91307C102$962.5K2,2961.0%
Inhibrx Biosciences Inc(INBX)COM45720N103$551.6K16,3770.6%
Fulcrum Therapeutics Inc(FULC)COM359616109$525.7K57,1410.5%
LB Pharmaceuticals Inc(LBRX)COM SHS50180M108$473.7K30,0000.5%
Revolution Medicines Inc(RVMD)COM76155X100$392.8K8,4110.4%
Unicycive Therapeutics Inc(UNCY)COM90466Y202$261.5K59,9850.3%
Nuvation BIO Inc -Cw27(NUVB/WS)*W EXP 07/07/202767080N119$18.4K90,8320.0%